FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / mcta-final-draft.docx
mcta-final-draft.docx · 1018-00004

Parties

Harkness LLP
Callahan LLP
Penterra Pharmaceuticals Corp

Dates

June 23, 2023
January 15, 2023
November 9, 2016
August 14, 2023

Amounts

$52,000
$75,000
$80,000,000
$62,400,000
$2,850,000
$40,000
$5,320,000
$1,500,000
$4,200,000
$1,230,000

Obligations

As used in this Agreement, the following terms shall have the meanings set forth below
1 shall have the meanings ascribed to them elsewhere in this Agreement
For purposes of this definition, "control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of an entity, whether through the ownership of voting securities, by contract, or otherwise, and the terms "controlled by" and "under common control with" shall be construed accordingly
Ownership of fifty percent (50%) or more of the voting securities of an entity shall be deemed to constitute control
Professor of Oncology at Graystone University Medical Center, who shall serve as the overall principal investigator for the CLARION trial across all Participating Sites, as further described in Article V
"Wind-Down Period" means the period of one hundred twenty (120) calendar days following the date on which a notice of termination is delivered by either Party in accordance with Article XVIII, during which the Parties shall undertake the wind-down activities described in Section 18